TIRAP

From WikiMD's WELLNESSPEDIA

Diagram of Toll-like receptor pathways, including TIRAP involvement.

TIRAP (Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein), also known as MAL (MyD88-adapter-like), is a critical adaptor protein involved in the signaling pathways of the innate immune system. It plays a pivotal role in the Toll-like receptor (TLR) signaling cascade, which is essential for the recognition of pathogen-associated molecular patterns (PAMPs) and the subsequent activation of immune responses.

Structure[edit]

TIRAP is characterized by the presence of a TIR domain, which is a conserved region found in all members of the TLR family and their associated adaptor proteins. This domain is crucial for protein-protein interactions that facilitate downstream signaling. The TIR domain of TIRAP allows it to interact with other TIR domain-containing proteins, such as MyD88, to propagate the signal initiated by TLR activation.

Function[edit]

TIRAP functions as a bridging adaptor that links specific TLRs to the downstream signaling adaptor MyD88. It is primarily involved in the signaling pathways of TLR2 and TLR4. Upon activation by their respective ligands, TLR2 and TLR4 recruit TIRAP to the plasma membrane, where it facilitates the recruitment of MyD88. This recruitment is essential for the activation of downstream signaling pathways that lead to the production of pro-inflammatory cytokines and type I interferons.

Role in Disease[edit]

Mutations or polymorphisms in the TIRAP gene have been associated with altered susceptibility to various infectious diseases. For example, certain polymorphisms in TIRAP have been linked to increased susceptibility to tuberculosis and malaria, while others may confer protection against these diseases. The role of TIRAP in inflammatory and autoimmune diseases is also an area of active research, as dysregulation of TLR signaling can contribute to chronic inflammation and autoimmunity.

Related Proteins[edit]

TIRAP is one of several adaptor proteins involved in TLR signaling. Other key adaptors include MyD88, TRIF (TIR-domain-containing adapter-inducing interferon-_), and TRAM (TRIF-related adaptor molecule). Each of these adaptors is involved in distinct TLR signaling pathways, contributing to the specificity and diversity of the immune response.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.